SCHEMBL6405487

SCHEMBL6405487

Cc1ccc(CCn2c(Cc3ccccc3)nnc2SCc2ccccc2)cc1

nearest known ligand 0.56

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
SSTR4 P31391 3/20 0.56
SSTR3 P32745 3/20 0.56
SMN1; SMN2 Q16637 3/20 0.56
MEN1 O00255 2/20 0.56
KMT2A Q03164 2/20 0.56
ALDH1A1 P00352 4/20 0.56
NPSR1 Q6W5P4 2/20 0.53
LMNA P02545 2/20 0.50
TP53 P04637 1/20 0.50
TSHR P16473 1/20 0.50
L3MBTL1 Q9Y468 2/20 0.49
GAA P10253 1/20 0.49
ALPG P10696 1/20 0.49
HTT P42858 1/20 0.48
RAB9A P51151 1/20 0.47
SSTR2 P30874 1/20 0.47
CA12 O43570 1/20 0.47
CA1 P00915 1/20 0.47
CA2 P00918 1/20 0.47
CA9 Q16790 1/20 0.47

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL6404966 0.92 SSTR4 (0.63) SSTR4SSTR3SMN1; SMN2MEN1KMT2A
SCHEMBL4202689 0.87 ALDH1A1 (0.71) SMN1; SMN2MEN1KMT2AALDH1A1NPSR1
SCHEMBL6405135 0.82 SSTR4 (0.54) SSTR4SSTR3SMN1; SMN2MEN1KMT2A
SCHEMBL4204431 0.80 ALDH1A1 (0.75) SSTR4SSTR3SMN1; SMN2MEN1KMT2A
SCHEMBL6408118 0.80 L3MBTL1 (0.67) SMN1; SMN2MEN1KMT2AALDH1A1LMNA
SCHEMBL11512244 0.79 SSTR4 (0.60) SSTR4SSTR3SMN1; SMN2MEN1KMT2A
SCHEMBL6406050 0.78 MEN1 (0.51) SMN1; SMN2MEN1KMT2AALDH1A1NPSR1
SCHEMBL6402427 0.76 HTT (0.71) SMN1; SMN2MEN1KMT2AALDH1A1NPSR1
SCHEMBL16541376 0.75 ALDH1A1 (0.57) SMN1; SMN2MEN1KMT2AALDH1A1LMNA
SCHEMBL24173374 0.74 SSTR4 (0.53) SSTR4SSTR3SMN1; SMN2MEN1KMT2A

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20050288347-A1 Certain triazole-based compounds, compositions, and uses thereof AGRIUS GROUP, LLC. 2005-12-29 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20050288347-A1 Certain triazole-based compounds, compositions, and uses thereof ABCG2, ATP5ME, DNTT SSTR4 4786/4885SSTR3 4704/4885SMN1; SMN2 4793/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.